Read our news

On June 4th, as part of the 3rd edition of the National Biopharmaceutical Bioproduction Day (#JNBB2026) organized by France BioLead, HTL Biotechnology was pleased to open the doors of its Javené facility to students and teachers who came to learn about careers in bioproduction.

At HTL Biotechnology, a culture of safety is deeply ingrained in our daily operations and guides all of our industrial practices. It is part of a clear goal: striving for zero accidents by placing prevention at the heart of our actions.

We have renewed our EcoVadis assessment and achieved the Platinum level!

HTL Biotechnology recently took part in PCHi (Personal Care and Homecare Ingredients), one of the leading events for the personal care industry, held in Hangzhou, China.

From 17 February, we celebrate the Lunar New Year and step into the Year of the Fire Horse — a powerful symbol of drive, resilience, and forward momentum across Asia.
A time of renewal, ambition, and fresh opportunities for growth.

HTL Biotechnology took part in IMCAS 2026, one of the leading international congresses dedicated to aesthetic medicine and dermatology. This major event was an opportunity to highlight the company’s strategy, innovations, and commitment to advancing regenerative medicine through high-performance biopolymers.

HTL Biotechnology is recognized for the second consecutive year among France’s most dynamic and innovative mid-sized companies.

On October 28, 2025, HTL Biotechnology hosted its first-ever webinar, “Shaping the Future of Aesthetic Medicine with Premium Biopolymers,” a key initiative to strengthen our presence in Asia and promote the “Feel the Difference with HTL Inside” positioning among major players in aesthetic medicine.

This October, HTL Biotechnology turned pink to support breast cancer prevention.

HTL Biotechnology is the winner of the Responsible Care West Atlantic Trophy in the ‘Energy – Climate’ category for its project to reduce carbon emissions from distillation systems.

The European Society of Cataract and Refractive Surgeons (ESCRS) is a unique opportunity each year to connect with our clients and partners while gaining insights into the key trends shaping the future of ophthalmology.

We’re pleased to share our second CSR report, highlighting the actions and commitments we carried out throughout 2024.